Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, et al.
Journal of Addiction Medicine (2021) Vol. 16, Iss. 2, pp. 223-228
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108879-108879
Open Access | Times Cited: 56
Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger, Kirsten E. Smith, Albert Garcia‐Romeu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Kratom use as more than a “self-treatment”
Kirsten E. Smith, Kelly E. Dunn, Jeffrey M. Rogers, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 6, pp. 684-694
Closed Access | Times Cited: 37
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 317-334
Open Access | Times Cited: 17
Social, psychological, and substance use characteristics of U.S. adults who use kratom: Initial findings from an online, crowdsourced study.
Kirsten E. Smith, Kelly E. Dunn, Oliver Grundmann, et al.
Experimental and Clinical Psychopharmacology (2021) Vol. 30, Iss. 6, pp. 983-996
Open Access | Times Cited: 40
Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey.
Oliver Grundmann, Charles A. Veltri, Sara Morcos, et al.
Experimental and Clinical Psychopharmacology (2023) Vol. 31, Iss. 5, pp. 963-977
Open Access | Times Cited: 14
Kratom ( Mitragyna speciosa Korth.) Use Among Poly-Drug Users in Southeast Asia: A Systematic Review
Neshalatha Govarthnapany, Roman Gabrhelík, Darshan Singh
Journal of Psychoactive Drugs (2025), pp. 1-11
Closed Access
Endogenous opiates and behavior: 2022
Richard J. Bodnar
Peptides (2023) Vol. 169, pp. 171095-171095
Closed Access | Times Cited: 12
Omissions, Ambiguities, and Underuse of Causal Assessment Tools: a Systematic Review of Case Reports on Patients Who Use Kratom
Jeffrey D. Feldman, Destiny Schriefer, Kirsten E. Smith, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 293-303
Closed Access | Times Cited: 11
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26
Kratom’s Emergence and Persistence Within the US Polydrug Epidemic
Kirsten E. Smith, Jeffrey M. Rogers, Jeffrey D. Feldman
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 262-271
Open Access | Times Cited: 10
Diagnostic Ambiguities and Underuse of Clinical Assessment Tools: A Systematic Review of Case Reports on Kratom Addiction and Physical Dependence
Kirsten E. Smith, Jeffrey D. Feldman, Destiny Schriefer, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 282-292
Closed Access | Times Cited: 9
The Mitragyna speciosa (kratom) alkaloid mitragynine: analysis of adrenergic α2 receptor activity in vitro and in vivo
Samuel Obeng, Morgan L. Crowley, Marco Mottinelli, et al.
European Journal of Pharmacology (2024) Vol. 980, pp. 176863-176863
Open Access | Times Cited: 3
Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample
Kirsten E. Smith, Jeffrey M. Rogers, Justin C. Strickland
Journal of Psychoactive Drugs (2021) Vol. 54, Iss. 5, pp. 429-439
Open Access | Times Cited: 13
A Preliminary Inventory of Kratom (Mitragyna Speciosa) Products and Vendors on the Darknet and Cryptomarkets
Elisabeth Prevete, Valeria Catalani, Darshan Singh, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 4, pp. 485-495
Closed Access | Times Cited: 5
Kratom use and mental health: A systematic literature review and case example
Anil Bachu, Prakamya Singal, Brittany Griffin, et al.
Journal of Addictive Diseases (2023) Vol. 42, Iss. 4, pp. 301-312
Closed Access | Times Cited: 4
Kratom as a potential substance use disorder harm reduction agent
MeShell Green, Nina Vadiei, Charles A. Veltri, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Research and publication gaps on kratom and kratom products: a scoping review of current literature
Balasingam Vicknasingam, Thiruventhan Karunakaran, Marek C. Chawarski
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 4, pp. 282-291
Closed Access | Times Cited: 1
Kratom ( Mitragyna speciosa ) use in a sample of drug-dependent adolescents in rehabilitation for drug use in Malaysia
Darshan Singh, Mohd Aizuddin Azuan, Suresh Narayanan
Journal of Ethnicity in Substance Abuse (2023), pp. 1-16
Closed Access | Times Cited: 3
Kratom's rising role in the potential exacerbation of mental health disorders: A case report and review of the literature
Maxsaya Baez Nuñez, Annika Dhingra, Myra Dhingra, et al.
Psychiatry Research Case Reports (2022) Vol. 1, Iss. 2, pp. 100069-100069
Open Access | Times Cited: 3
Kratom (<i>Mitragyna speciosa</i>) Use and Mental Health: A Systematic Review and Multilevel Meta-Analysis
Yuting Yang, Christian P. Müller, Darshan Singh
European Addiction Research (2024) Vol. 30, Iss. 4, pp. 252-274
Closed Access
An in vitro evaluation on metabolism of mitragynine to 9-O-demethylmitragynine
Philip W. Melchert, Qingchen Zhang, John S. Markowitz
Chemico-Biological Interactions (2024), pp. 111247-111247
Closed Access
Aggression in a Cohort of Male Methamphetamine (METH) Users With and Without Kratom ( Mitragyna speciosa Korth.) Use History in Malaysia
Yuting Yang, Christian P. Müller, Darshan Singh
Journal of Psychoactive Drugs (2024), pp. 1-12
Closed Access
The neuropharmacology of kratom, a novel psychoactive natural product
MeShell Green, Charles A. Veltri, Walter C. Prozialeck, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111215-111215
Closed Access
Page 1 - Next Page

Scroll to top